Victoza (liraglutide) was approved June 17, 2019, for pediatric patients 10 years of age and older for the treatment of type 2 diabetes. This is the first non-insulin drug approved to treat type 2 diabetes in children since metformin was approved for pediatric patients in 2000.
Stem Cells therapy
Stem cell therapy for liver
The patients with decompensated cirrhosis mostly have to opt for liver transplantation, but the limited availability of donor organs and high cost results in high waitlist mortality . Stem cells of one’s own body help Read more…
